发明名称 |
Antisense antibacterial method and compound |
摘要 |
A method and antisense compound for inhibiting the growth of pathogenic bacterial cells are disclosed. The compound contains no more than 12 nucleotide bases and has a targeting nucleic acid sequence of no fewer than 10 bases in length that is complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication. The compound binds to a target mRNA with a Tm of between 50° to 60° C. The relatively short antisense compounds are substantially more active than conventional antisense compounds having a targeting base sequence of 15 or more bases. |
申请公布号 |
US9534220(B2) |
申请公布日期 |
2017.01.03 |
申请号 |
US201213680790 |
申请日期 |
2012.11.19 |
申请人 |
Sarepta Therapeutics, Inc. |
发明人 |
Geller Bruce L.;Deere Jesse D.;Iversen Patrick L. |
分类号 |
C12N15/113;C07F9/6558;C07F9/6561 |
主分类号 |
C12N15/113 |
代理机构 |
Seed IP Law Group LLP |
代理人 |
Seed IP Law Group LLP |
主权项 |
1. A method of inhibiting the growth of pathogenic bacterial cells, comprising
exposing the bacterial cells to a growth-inhibiting amount of a substantially uncharged antisense oligonucleotide compound
of 10 to 12 bases in length having a targeting sequence of at least 10 bases that are complementary to a target sequence containing or within 10 bases downstream of the translational start codon of a bacterial mRNA that encodes a bacterial protein selected from the group consisting of acyl carrier protein (acpP), gyrase A subunit (gyrA), and the cell division protein ftsZ, wherein the antisense oligonucleotide compoundis a morpholino antisense oligonucleotide. |
地址 |
Corvallis OR US |